Jason Katz, the Chief Executive Officer of Intelligent Protection Management Corp., has recently increased his ownership stake in the company through multiple stock transactions. This development is significant as it indicates Katz's confidence in the company's prospects.
According to a filing made on November 17, 2026, Katz acquired a total of 10,000 shares of common stock over three transactions. The most recent transaction involved the purchase of 7,857 shares at a price of $1.75 per share on November 17, 2026. Following these transactions, Katz now owns 677,803 shares of Intelligent Protection Management Corp.
Background
Intelligent Protection Management Corp. is a company engaged in services related to computer programming and data processing. The company is headquartered in Jericho, New York, and has undergone several name changes in the past, including its former names Paltalk, Inc. and PeerStream, Inc. Its Central Index Key (CIK) is 0001355839, and it operates under the SIC code for services in computer programming and data processing.
What the Filing Says
The recent filing, with accession number 0001213900-26-121462, outlines Katz's transactions on specific dates, including November 13, November 16, and November 17, 2026. The filing states that Katz acquired 2,000 shares on November 13 at $1.73 each, followed by 143 shares on November 16 at $1.70 each, and the aforementioned 7,857 shares on November 17 at $1.75 each.
Impact
This increase in ownership may positively influence the perception of Intelligent Protection Management Corp. among investors. Katz's actions could signal a strong belief in the company's future performance, potentially impacting stockholder sentiment and the company's market reputation.
What's Next
The filing does not say what happens next.
Read Next
NeuroPace CFO Acquires 11,891 Shares of Common Stock
Medicus Pharma director acquires 14,534 shares at $1.72
Yingling files ownership report after Bright Horizon merger
Brennan Edward J. acquires shares in Medicus Pharma Ltd.
Ciaruffoli acquires 72,674 shares in Medicus Pharma Ltd.
NeuroPace CEO Becker Joel Acquires 11,891 Shares








